Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Acute/Subacute Toxicity of Nano Calcium

나노 칼슘의 급성/아급성 안전성 평가

  • Received : 2014.09.30
  • Accepted : 2014.10.15
  • Published : 2015.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

The objective of this study was to obtain data on the safety-in-use of nano calcium as a dietary supplement by assessing its acute and subacute oral toxicities in female and male Sprague-Dawley rats. A single oral dose of 5,000 mg/kg of nano calcium did not result in mortality or significant changes in the general behavior and gross appearance of the internal organs of rats. For subacute toxicity study, nano calcium was administered orally at a dose of 1,000 mg/kg daily for 14 days. There were no significant differences in organ weights between control and treated groups of both sexes. Hematological analysis and blood chemistry revealed no toxic effects of nano calcium. Pathologically, neither gross abnormalities nor histopathological changes were observed. These results show that nano calcium possesses very low toxicity as indicated in a rat model.

본 연구에서는 난각 칼슘을 이용하여 분획 공정을 통해 나노칼슘을 제조(입자 크기가 96.5 nm)하였으며 이에 대해 안전성 평가를 위해 OECD guideline에 따라 동물을 이용하여 단회투여의 급성 독성시험과 반복투여의 아급성 독성시험을 실시하였다. 그 결과 급성 및 아급성 독성시험의 모든 암수동물에서 나노 칼슘의 투여에 기인된 사망은 관찰되지 않았으며 나노 칼슘은 모든 암수 rat에 대하여 대조군과 비교하여 유의성 있는 체중 변화를 초래하지 않았다. 또한 나노 칼슘 투여군에서 특이한 임상 증상 및 부검 시 내부 장기의 어떠한 육안적 이상소견도 관찰되지 않았다. 따라서 급성 및 아급성 독성시험의 결과 나노 칼슘은 혈액과 장기 등 평가 지표에 독성으로 인한 영향을 나타내지 않으며 안전한 것으로 판단되었다.

Keywords

References

  1. Heaney RP. 2000. Calcium, dairy products and osteoporosis. J Am Coll Nutr 19: 83S-99S. https://doi.org/10.1080/07315724.2000.10718088
  2. Denk E, Hillegonds D, Hurrell RF, Vogel J, Fattinger K, Haselmann HJ, Kraenzlin M, Walczyk T. 2007. Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass. J Bone Miner Res 22: 1518-1525. https://doi.org/10.1359/jbmr.070617
  3. Lee S, Chang SO. 1994. Comparison of the bioavailability of calcium from anchovy, tofu and nonfat dry milk (NFDM) in growing male rats. Korean J Nutr 27: 473-482.
  4. Lee SH, Hwangbo YS, Kim JY, Lee YS. 1997. A study on the bioavailability of dietary calcium sources. Korean J Nutr 30: 499-505.
  5. Kim JS, Choi JD, Kim DS. 1998. Preparation of calcium based powder from fish bone and its characteristics. J Korean Soc Appl Biol Chem 41: 147-152.
  6. Han JH, Choi HS, Ra KS, Chung S, Suh HJ. 2014. Intestinal permeability of oyster shell calcium with different particle sizes. J Korean Soc Food Sci Nutr 43: 454-458. https://doi.org/10.3746/jkfn.2014.43.3.454
  7. Chen HS, Chang JH, Wu JSB. 2008. Calcium bioavailability of nanonized pearl powder for adults. J Food Sci 73: H246- H251. https://doi.org/10.1111/j.1750-3841.2008.00965.x
  8. Vaikousi H, Lazaridou A, Biliaderis CG, Zawistowski J. 2007. Phase transitions, solubility, and crystallization kinetics of phytosterols and phytosterol-oil blends. J Agric Food Chem 55: 1790-1798. https://doi.org/10.1021/jf0624289
  9. Peters R, Dam G, Bouwmeester H, Helsper H, Allmaier G, Kammer F, Ramsch R, Solans C, Tomaniova M, Hajslova J, Weigel S. 2011. Identification and characterization of organic nanoparticles in food. Trends Anal Chem 30: 100-112. https://doi.org/10.1016/j.trac.2010.10.004
  10. Gokmen V, Mogol BA, Lumaga RB, Fogliano V, Kaplun Z, Shimoni E. 2011. Development of functional bread containing nanoencapsulated omega-3 fatty acids. J Food Eng 105: 585-591. https://doi.org/10.1016/j.jfoodeng.2011.03.021
  11. Hou JG, Wang Y, Xu W, Yang L, Wu ZQ, Zhang YH. 1998. Formation of (110) oriented layered silver nano-crystallites. Mater Lett 34: 36-39. https://doi.org/10.1016/S0167-577X(97)00145-6
  12. Douroumin D, Fahr A. 2006. Nano- and micro-particulate formulations of poorly water-soluble drugs by using a novel optimized technique. Eur J Pharm Biopharm 63: 173-175. https://doi.org/10.1016/j.ejpb.2006.02.004
  13. Thomas K, Sayre P. 2005. Research strategies for safety evaluation of nanomaterials, Part I: Evaluating the human health implications of exposure to nanoscale materials. Toxicol Sci 87: 316-321. https://doi.org/10.1093/toxsci/kfi270
  14. Organisation of Economic Co-operation and Development (OECD). 2001. The OECD Guideline for Testing of Chemical: 420 Acute Oral Toxicity. OECD, Paris, France.
  15. Organisation of Economic Co-operation and Development (OECD). 2001. The OECD Guideline for Testing of Chemical: 407 Repeated Dose Oral Toxicity-Rodent: 28-Day or 14-Day Study. OECD, Paris, France.
  16. Organisation of Economic Co-operation and Development (OECD). 2001. OECD Guidelines for Testing of Chemical: 423 Acute Oral Toxicity-Acute Class Method. OECD, Paris, France.
  17. Giknis MLA, Clifford CB. 2006. Clinical laboratory parameters for Crl:CD (SD) rats. Charles River Laboratories Inc., Wilmington, MA, USA.